ChargePoint Technology Launches Smart Monitoring Technology at Achema 2018

Article

The technology, known as Verifi, is available with the ChargePoint’s range of valves that ensure safe and contamination-free handling of API and other formulation ingredients.

ChargePoint Technology, a supplier of powder containment and aseptic transfer valve, has launched a smart monitoring hub to support efficiency and safety within chemical and pharmaceutical manufacturing processes. The company will be exhibiting its new Verifi solution at Achema 2018.

ChargePoint contained transfer devices are used to ensure integrity of product handling during high potency and sterile manufacturing. With Verifi, manufacturers have an automatic and reliable method of understanding the health status of the device, allowing them to better control risk and ensure consistent integrity throughout the lifecycle of the system and its critical components. 

Verifi is connected directly onto the ChargePoint active valve unit; it continuously records data and delivers alerts to its users. Its LED display provides operators with visual feedback. Service advice allows maintenance teams to take preventative action, resulting in less downtime and improved efficiency.

Data can also be synchronized via WiFi to the secure Verifi portal, where data are stored in the cloud for production and process managers to analyse remotely and export for further reporting.

ChargePoint Technology’s other solutions include its AseptiSafe range, which provides increased sterility assurance for ingredient and small component transfers in aseptic processing and sterile API production. The PharmaSafe powder containment valves offer high level of containment performance to ensure the safe handling of potent APIs, intermediates, and pharmaceutical formulations.

Source: ChargePoint, Hall 3.0, Booth D14

 

Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines, episode 7
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content